Shares of Clariant AG (OTCMKTS:CLZNY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, two have given a buy recommendation and two have issued a strong buy recommendation on the company.
A number of equities research analysts recently issued reports on CLZNY shares. The Goldman Sachs Group raised Clariant to a “strong-buy” rating in a research note on Thursday, August 20th. Morgan Stanley reissued an “underweight” rating on shares of Clariant in a research note on Tuesday. Zacks Research upgraded Clariant from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft raised shares of Clariant from a “hold” rating to a “buy” rating in a research report on Monday, August 3rd. Finally, Jefferies Financial Group raised Clariant from a “moderate sell” rating to a “hold” rating in a research report on Thursday, August 6th.
Check Out Our Latest Analysis on CLZNY
Clariant Stock Performance
Clariant Company Profile
Clariant AG is a Switzerland-based specialty chemicals company that develops and manufactures products used by industrial and consumer-goods companies. Its portfolio includes specialty ingredients, functional additives, catalysts, adsorbents, and other chemical solutions designed to improve the performance, efficiency, safety, or sustainability of customers’ products and manufacturing processes.
The company operates through businesses focused on Care Chemicals, Catalysts, and Adsorbents & Additives.
See Also
- Five stocks we like better than Clariant
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.
